These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Dyskinetopsia during light adaptation associated with nefazodone treatment. Hundal KS; Chen S; Moore W; Tranos P; Joshi N Eye (Lond); 2003 Nov; 17(9):1040-2. PubMed ID: 14704758 [No Abstract] [Full Text] [Related]
12. Six-year perspectives on the safety and tolerability of nefazodone. Dunner DL; Laird LK; Zajecka J; Bailey L; Sussman N; Seabolt JL J Clin Psychiatry; 2002; 63 Suppl 1():32-41. PubMed ID: 11890563 [No Abstract] [Full Text] [Related]
13. [Acute liver failure ascribed to nefazodone: importance of 'postmarketing surveillance' for recently introduced drugs]. van Battum PL; van de Vrie W; Metselaar HJ; Verstappen VM; Zondervan PE; de Man RA Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1964-7. PubMed ID: 11048561 [TBL] [Abstract][Full Text] [Related]
17. Nefazodone (Serzone) withdrawn because of hepatotoxicity. Choi S CMAJ; 2003 Nov; 169(11):1187. PubMed ID: 14638657 [No Abstract] [Full Text] [Related]
18. Withdrawing drugs: nefazodone, the start of the latest saga. Edwards IR Lancet; 2003 Apr; 361(9365):1240. PubMed ID: 12699949 [No Abstract] [Full Text] [Related]